Trial · NCT03233737
Outcomes22
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Stage II: Duration of Anesthesia as Measured by Pin Prick Test (PPT) for One Spray CTY-5339-A Compared to One Spray CTY-5339-CB | Up to one hour post-application | minutes | MEAN | |
| PRIMARY | Stage II: Duration of Anesthesia as Measured by Heat Sensation Threshold (QST Heat) for One Spray CTY-5339-A Compared to One Spray CTY-5339-CB | Up to one hour post-application | minutes | MEAN | |
| PRIMARY | Stage I: Duration of Anesthesia as Measured by Pin Prick Test (PPT) for One Spray CTY-5339-A Compared to One Spray CTY-5339-CB Compared to One Spray CTY-5339-P (Placebo: Vehicle Control) | Up to one hour post-application | Placebo duration of effect was not analyzed. | minutes | MEAN |
| PRIMARY | Stage I: Duration of Anesthesia as Measured by Heat Sensation Threshold (QST Heat) for One Spray CTY-5339-A Compared to One Spray CTY-5339-CB Compared to One Spray CTY-5339-P (Placebo: Vehicle Control) | Up to one hour post-application | minutes | MEAN | |
| SECONDARY | Stage II: Onset of Anesthesia for Pin Prick Test (PPT) | Up to one hour post-application | minutes | MEAN | |
| SECONDARY | Stage II: Onset of Anesthesia for Heat Sensation Threshold (QST Heat) | Up to one hour post-application | minutes | MEAN | |
| SECONDARY | Stage II: Percentage of Responders for Pin Prick Test (PPT) at Each Time Point | Up to one hour post-application | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Stage II: Percentage of Responders for Heat Sensation Threshold (QST Heat) at Each Time Point | Up to one hour post-application | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Stage II: Percentage of Subjects Reaching Minimal Pain on Pin Prick Test (PPT) (≤2 on Numerical Rating Scale Pain Scale) | Any time within one hour post-application | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Stage II: Duration of Minimal Pain for Pin Prick Test (PPT) (≤2 on Numerical Rating Scale Pain Scale) | Up to one hour post-application | minutes | MEAN | |
| SECONDARY | Stage II: Percentage of Subjects Reaching Maximum Heat for Heat Sensation Threshold (QST Heat) | Any time within one hour post-application | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Stage II: Sum of Pain Intensity Differences (SPID) for Pin Prick Test (PPT) (Post-hoc) | Up to one hour post-application | score | MEAN | |
| SECONDARY | Stage II: Sum of Temperature Differences (STID) for Heat Sensation Threshold (QST Heat) (Post-hoc) | Up to one hour post-application | Degrees Celcius (ºC) | MEAN | |
| SECONDARY | Stage I: Percentage of Responders for Pin Prick Test (PPT) at Each Time Point | Time of application up to one hour post-application | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Stage I: Percentage of Responders for Heat Sensation Threshold (QST Heat) at Each Time Point | Time of application up to one hour post-application | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Stage I: Duration of Minimal Pain for Pin Prick Test (PPT) (≤2 on Numerical Rating Scale Pain Scale) | Up to one hour post-application | minutes | MEAN | |
| SECONDARY | Stage I: Percentage of Subjects Reaching Maximum Heat for Heat Sensation Threshold (QST Heat) | Any time within one hour post-application | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Stage I: Onset of Anesthesia for Pin Prick Test (PPT) | Up to one hour post-application | minutes | MEAN | |
| SECONDARY | Stage I: Onset of Anesthesia for Heat Sensation Threshold (QST Heat) | Up to one hour post-application | minutes | MEAN | |
| SECONDARY | Stage I: Percentage of Subjects Reaching Minimal Pain on Pin Prick Test (PPT) (≤2 on Numerical Rating Scale Pain Scale) | Any time within one hour post-application | Placebo percentage of response was not analyzed. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03233737/outcomes